Lunit

About Lunit

Lunit is a medical AI company focused on improving early cancer detection and optimizing treatment strategies through advanced imaging and biomarker analysis. The platform specializes in analyzing chest X-rays and mammograms to identify potential signs of lung and breast cancer, helping radiologists prioritize suspicious cases and reduce diagnostic delays. By integrating AI into the screening workflow, Lunit aims to increase accuracy and efficiency in radiology departments, particularly for large-scale or routine exams where subtle lesions might otherwise be overlooked.

Beyond screening, Lunit’s technology extends to AI-driven biomarker analysis for immunotherapy and oncology treatment planning. The company’s tools are designed to support clinical decision-making by providing quantitative insights from medical images, which can help predict patient responses to specific therapies. This dual focus on early detection and treatment optimization positions Lunit as a comprehensive AI solution within radiology and oncology, though the full scope of its clinical integration and regulatory clearances depends on regional approvals and healthcare partnerships.